AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Trial: 28120591
Drug: Oral indomethacin
RxNorm normalized name: Indomethacin
DrugBank: Indomethacin (DB00328)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Oral indomethacin (0.2 mg/kg daily for 3 days)
Trial: 20061726
Drug: Control lotion
RxNorm normalized name: Afeditab CR
DrugBank: Nifedipine (DB01115)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Control lotion applied daily for 10 weeks
Trial: 18070245
Drug: Naltrexone 50
RxNorm normalized name: naltrexone 50 mg oral tablet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Naltrexone 50 mg/d
Trial: 9865813
Drug: High structured
RxNorm normalized name: high-density polyethylene
FDA approved: no
EMA approved: no
PMDA approved: no
Description: High structured treatment
Trial: 333906
Drug: Bovine lung
RxNorm normalized name: defibrotide, bovine lung
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Bovine lung heparin (2 units/ml)
Trial: 333906
Drug: Comparison of
RxNorm normalized name: OIL OF CAMPHOR
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Comparison of bovine lung heparin and porcine intestinal heparin
Trial: 20687931
Drug: Polypill-based strategy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Polypill-based strategy (single capsule containing aspirin, a statin, and two blood pressure-lowering agents)
Trial: 18272344
Drug: Serrapeptase 5mg
RxNorm normalized name: Serrapeptase
DrugBank: Serrapeptase (DB13131)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Serrapeptase 5mg + 1000 mg paracetamol
Trial: 18272344
Drug: Placebo +
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo + 1000 mg paracetamol
Trial: 16167356
Drug: Caffeine (200
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Caffeine (200 mg twice a day for 3 days)
Trial: 408844
Drug: d-amphetamine 10
RxNorm normalized name: amphetamine / dextroamphetamine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: d-amphetamine 10 mg
Trial: 8719123
Drug: pimozide 1
RxNorm normalized name: pimozide 1 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: pimozide 1 mg
Trial: 8719123
Drug: pimozide 2
RxNorm normalized name: pimozide 2 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: pimozide 2 mg
Trial: 1389818
Drug: Infusion of
RxNorm normalized name: OIL OF CAMPHOR
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Infusion of 0.125% bupivacaine (group B)
Trial: 3885918
Drug: Topical prostaglandin
RxNorm normalized name: Prostaglandin D2
DrugBank: Prostaglandin D2 (DB02056)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Topical prostaglandin E2 (PGE2)
Trial: 28631234
Drug: Higher dosage
RxNorm normalized name: osage orange pollen extract
DrugBank: Maclura pomifera pollen (DB10988)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Higher dosage of the PATHS curriculum
Trial: 24939489
Drug: Sevoflurane (1.0
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Sevoflurane (1.0 MAC) + low-dose i.v. remifentanil (0.028 μg/kg per minute)
Trial: 20594220
Drug: Mosapride 15
RxNorm normalized name: mosapride
DrugBank: Mosapride (DB11675)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Mosapride 15 mg/day
Trial: 9692655
Drug: Famotidine 40
RxNorm normalized name: famotidine 40 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Famotidine 40 mg/day
Trial: 15943844
Drug: Tandospirone 30
RxNorm normalized name: Tandospirone
DrugBank: Tandospirone (DB12833)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Tandospirone 30 mg/day
Trial: 27933348
Drug: Drug-based treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Drug-based treatment (NSAIDs only)
Trial: 18158850
Drug: Pure substances
RxNorm normalized name: Dream Pure BB
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Pure substances in hard gelatin capsules (reference)
Trial: 15867044
Drug: CCK‐OP (0.04
FDA approved: no
EMA approved: no
PMDA approved: no
Description: CCK‐OP (0.04 mug/kg per dose, twice daily)
Trial: 7543598
Drug: Zanoterone 200
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Zanoterone 200 mg
Trial: 1298631
Drug: Oral quinine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral quinine bisulfate 10mg/kg 8 hourly for a total of 7 days when patients were well enough (after initial loading dose)
Trial: 1298631
Drug: Standard treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Standard treatment without initial loading dose
Trial: 6470965
Drug: Once daily
RxNorm normalized name: GEL, ONCE DAILY
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Once daily (3000 mg of salicylate)
Trial: 6470965
Drug: Both dosage
RxNorm normalized name: osage orange pollen extract
DrugBank: Maclura pomifera pollen (DB10988)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Both dosage schedules
Trial: 30772699
Drug: Usual care
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Usual care (UC) treatment
Trial: 12183351
Drug: Subcutaneous infusion
RxNorm normalized name: subcutaneous infusion pump
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Subcutaneous infusion of lisuride
Trial: 12183351
Drug: Oral levodopa
RxNorm normalized name: Levodopa
DrugBank: Levodopa (DB01235)
FDA approved: yes
EMA approved: yes
PMDA approved: no
Description: Oral levodopa and dopamine agonists (control)
Trial: 3689626
Drug: DPI 201-106
RxNorm normalized name: treprostinil
DrugBank: Treprostinil (DB00374)
FDA approved: yes
EMA approved: yes
PMDA approved: no
Description: DPI 201-106 (30 mg)
Trial: 3689626
Drug: DPI 201-106
RxNorm normalized name: treprostinil
DrugBank: Treprostinil (DB00374)
FDA approved: yes
EMA approved: yes
PMDA approved: no
Description: DPI 201-106 (60 mg)
Trial: 20388917
Drug: Physiological saline
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Physiological saline and ciprofloxacin 2 × 200 mg/d intravenously (placebo group)
Trial: 18427974
Drug: Letrozole 5
RxNorm normalized name: Letrozole
DrugBank: Letrozole (DB01006)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Letrozole 5 mg/day (n = 70) on days 3-7 of the menstrual cycles
Trial: 18427974
Drug: Clomiphene citrate
RxNorm normalized name: Clomiphene Citrate
DrugBank: Clomifene (DB00882)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Clomiphene citrate (CC) 100 mg/day combined with human menopausal gonadotropin (hMG) 75 IU/ml
Trial: 12588933
Drug: 4 mg
RxNorm normalized name: lutein 4 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 4 mg reboxetine
Trial: 12841697
Drug: 50 microg
RxNorm normalized name: Digoxin 250 microgram oral tablet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 50 microg vaginal misoprostol 6 hourly (group 1, n = 60)
Trial: 1400933
Drug: GnRH agonist
RxNorm normalized name: GnRH
DrugBank: Gonadorelin (DB00644)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: GnRH agonist (GnRHa) buserelin continued during HMG treatment
Trial: 3890510
Drug: Propafenone (300
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Propafenone (300 mg every 12 hours during low-dose week, 300 mg every 8 hours during high-dose week)
Trial: 27912951
Drug: Homeopathic cold
RxNorm normalized name: Boiron Homeopathic Cold Calm Cold Relief
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Homeopathic cold syrup
Trial: 16019355
Drug: Testosterone undecanoate
RxNorm normalized name: Testosterone Undecanoate
DrugBank: Testosterone undecanoate (DB13946)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Testosterone undecanoate 40 mg plus estradiol valerate 2 mg daily
Trial: 12626215
Drug: Placebo plus
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo plus estradiol valerate 2 mg daily
Trial: 9925834
Drug: Budesonide inhalation
RxNorm normalized name: Budesonide Inhalation Powder
DrugBank: Budesonide (DB01222)
FDA approved: yes
EMA approved: yes
PMDA approved: yes
Description: Budesonide inhalation suspension (BIS) 0.25 mg once daily (QD)
Trial: 9925834
Drug: Budesonide inhalation
RxNorm normalized name: Budesonide Inhalation Powder
DrugBank: Budesonide (DB01222)
FDA approved: yes
EMA approved: yes
PMDA approved: yes
Description: Budesonide inhalation suspension (BIS) 0.25 mg twice a day (BID)
Trial: 9925834
Drug: Budesonide inhalation
RxNorm normalized name: Budesonide Inhalation Powder
DrugBank: Budesonide (DB01222)
FDA approved: yes
EMA approved: yes
PMDA approved: yes
Description: Budesonide inhalation suspension (BIS) 0.5 mg BID
Trial: 9925834
Drug: Budesonide inhalation
RxNorm normalized name: Budesonide Inhalation Powder
DrugBank: Budesonide (DB01222)
FDA approved: yes
EMA approved: yes
PMDA approved: yes
Description: Budesonide inhalation suspension (BIS) 1.0 mg QD
Trial: 656715
Drug: In-patient treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: In-patient treatment for three months
Trial: 28257617
Drug: 2 sessions
RxNorm normalized name: Alpinia Sessilis Root
DrugBank: Kaempferia galanga root (DB14288)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 2 sessions of cervicothoracic manipulation and range‐of‐motion exercises followed by 6 sessions of stretching and strengthening exercise (manipulative‐therapy‐plus‐exercise group)
Trial: 25951477
Drug: Daily cleaning
RxNorm normalized name: Oxy Daily Cleaning
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Daily cleaning with multipurpose disinfection solution (MPDS)
Trial: 25951477
Drug: Control (no
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control (no daily cleaning)
Trial: 18327066
Drug: Beta-adrenergic blockers
RxNorm normalized name: Beta Carotene
DrugBank: Beta carotene (DB06755)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Beta-adrenergic blockers
Trial: 6134467
Drug: Oral isosorbide
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral isosorbide dinitrate
Trial: 6134467
Drug: 2 percent
RxNorm normalized name: ALCOHOL 62 mL in 100 mL TOPICAL GEL [The Keeps ETHANOL 62 percent]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 2 percent nitroglycerin ointment
Trial: 24399088
Drug: Ampicillin or
RxNorm normalized name: ampicillin Oral Tablet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ampicillin or Amoxicillin
Trial: 21537858
Drug: Pulsed electromagnetic
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Pulsed electromagnetic field at radiofrequencies, 30 min daily, 5 consecutive days per week for 2 weeks
Trial: 11705489
Drug: Imatinib (various
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Imatinib (various doses)
Trial: 20056639
Drug: Interactive, tailored
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Interactive, tailored computer instruction at baseline and four monthly lay health advisor counseling sessions
Trial: 20056639
Drug: Low-dose comparison
RxNorm normalized name: ethinyl estradiol
DrugBank: Ethinylestradiol (DB00977)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Low-dose comparison group consisting of a culturally appropriate mammography screening pamphlet
Trial: 8681493
Drug: Mazapertine (20
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Mazapertine (20 or 30 mg)
Trial: 8681493
Drug: Mazapertine (40
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Mazapertine (40 mg)
Trial: 8681493
Drug: Mazapertine (incremental
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Mazapertine (incremental dosing)
Trial: 1920817
Drug: Ketanserin (KET)
RxNorm normalized name: ketanserin
DrugBank: Ketanserin (DB12465)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ketanserin (KET) 40 mg
Trial: 6227244
Drug: megadose multi-vitamin/mineral
FDA approved: no
EMA approved: no
PMDA approved: no
Description: megadose multi-vitamin/mineral supplement for 4 months
Trial: 14978984
Drug: Control group
RxNorm normalized name: meningococcal group B vaccine Prefilled Syringe [Trumenba]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control group (no drug)
Trial: 25491391
Drug: MSC treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: MSC treatment in combination with everolimus and prednisolone
Trial: 25491391
Drug: Control group
RxNorm normalized name: meningococcal group B vaccine Prefilled Syringe [Trumenba]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control group receiving everolimus, prednisolone, and standard dose tacrolimus
Trial: 17985420
Drug: Sequential monotherapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Sequential monotherapy (Group 1)
Trial: 17985420
Drug: Step‐up to
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Step‐up to combination therapy (Group 2)
Trial: 11896097
Drug: Postoperative hepatic
RxNorm normalized name: hepatitis nosodes
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Postoperative hepatic arterial floxuridine combined with intravenous continuous‐infusion fluorouracil (chemotherapy arm)
Trial: 9036320
Drug: Inhaled nitric
RxNorm normalized name: nitric oxide Inhalant Product
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Inhaled nitric oxide (20 ppm)
Trial: 15722809
Drug: Medication use
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Medication use
Trial: 31095954
Drug: PPV plus
FDA approved: no
EMA approved: no
PMDA approved: no
Description: PPV plus IVB (1.25 mg bevacizumab)
Trial: 20154071
Drug: Standard oxygen
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Standard oxygen therapy (control)
Trial: 22222299
Drug: Citracal Petite
RxNorm normalized name: Citracal Petites
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Citracal Petite (tablet formulation of calcium citrate)
Trial: 20214047
Drug: Serum insulin-like
RxNorm normalized name: insulin-like growth factor 2
DrugBank: Insulin-like growth factor II (DB14472)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Serum insulin-like growth factor-1 (IGF-1) level
Trial: 9863095
Drug: Ginkgo leave
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ginkgo leave concentrated oral liquor (GLC)
Trial: 25178668
Drug: Ticagrelor (180
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ticagrelor (180 mg loading dose)
Trial: 24314422
Drug: Anterior chamber
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Anterior chamber paracentesis (ACP) and medical treatment (group 1)
Trial: 3518423
Drug: Tunneled subcutaneous
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Tunneled subcutaneous catheters
Trial: 24802090
Drug: Five 1‐hr
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Five 1‐hr milieu communication teaching (MCT) sessions per week (daily treatment)
Trial: 24802090
Drug: Parental linguistic
RxNorm normalized name: C.I. direct red 28 parent
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Parental linguistic mapping measured after 6 months of treatment
Trial: 3174738
Drug: Nicotine gum
RxNorm normalized name: Equate Nicotine Gum 4mg Starter Kit
DrugBank: Nicotine (DB00184)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Nicotine gum (4 mg)
Trial: 1559737
Drug: Vehicle for
RxNorm normalized name: ORAL SUSPENDING COMPOUND PLUS SUSPENSION VEHICLE (VEHICLE FOR ORAL SUSPENSION)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Vehicle for ciclopirox olamine cream
Trial: 23062392
Drug: Fluticasone furoate
RxNorm normalized name: Fluticasone Furoate
DrugBank: Fluticasone furoate (DB08906)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Fluticasone furoate (FF) 100 μg once daily
Trial: 23062392
Drug: Fluticasone furoate
RxNorm normalized name: Fluticasone Furoate
DrugBank: Fluticasone furoate (DB08906)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Fluticasone furoate (FF) 200 μg once daily
Trial: 22342538
Drug: Fluticasone propionate
RxNorm normalized name: Fluticasone Propionate
DrugBank: Fluticasone propionate (DB00588)
FDA approved: yes
EMA approved: yes
PMDA approved: yes
Description: Fluticasone propionate (FP) 100 μg twice daily
Trial: 18343264
Drug: Levetiracetam 5000
RxNorm normalized name: Levetiracetam
DrugBank: Levetiracetam (DB01202)
FDA approved: yes
EMA approved: yes
PMDA approved: no
Description: Levetiracetam 5000 mg
Trial: 8750042
Drug: 7% CO2
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 7% CO2 inhalation
Trial: 17547588
Drug: Topiramate (25-600
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Topiramate (25-600 mg/day)
Trial: 10555933
Drug: Celecoxib 200
RxNorm normalized name: celecoxib 200 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Celecoxib 200 mg twice/day
Trial: 10555933
Drug: Naproxen 500
RxNorm normalized name: naproxen 500 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Naproxen 500 mg twice/day
Trial: 15741734
Drug: Quinapril (ACE
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Quinapril (ACE inhibitor)
Trial: 26963851
Drug: Capsaicin (0.1
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Capsaicin (0.1 mg) injected into the intermetatarsal space
Trial: 26963851
Drug: Capsaicin (0.1
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Capsaicin (0.1 mg)
Trial: 12843167
Drug: Combined treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combined treatment (10 mg atorvastatin and 900 mg gemfibrozil)
Trial: 8635380
Drug: 30 mg
RxNorm normalized name: agar 30 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 30 mg Morphine plus 25 mg Promethazine (M-P)
Trial: 8635380
Drug: 30 mg
RxNorm normalized name: agar 30 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 30 mg Morphine plus 10 mg Prochlorperazine (M-PC)
Trial: 1461870
Drug: Dopamine (high
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Dopamine (high doses)
Trial: 1461870
Drug: Dobutamine (low
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Dobutamine (low doses)
Trial: 1461870
Drug: Dopamine (low
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Dopamine (low doses)
Trial: 3867301
Drug: Cranial irradiation
RxNorm normalized name: geranial
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cranial irradiation (24Gy) plus i.t. MTX, 6 doses (Modality A)
Trial: 3867301
Drug: i.t. MTX
FDA approved: no
EMA approved: no
PMDA approved: no
Description: i.t. MTX and ARA-C, 10 doses (6 weekly and 4 monthly) (Modality B)
Trial: 3867301
Drug: Standard-risk (SR)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Standard-risk (SR) therapy with PRED, VCR, ASPAR for remission induction and MP and MTX for maintenance
Trial: 3867301
Drug: High-risk (HR)
RxNorm normalized name: high-density polyethylene
FDA approved: no
EMA approved: no
PMDA approved: no
Description: High-risk (HR) therapy with 4 drugs including DAUNO, PRED, VCR, and DAUNO for reinductions every 3 months
Trial: 22859563
Drug: Conventional fractionation
RxNorm normalized name: LIVER FRACTION
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Conventional fractionation (CF) with a median dose of 60 Gy and median OTT of 47 days
Trial: 22859563
Drug: Overall treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Overall treatment time (OTT) ≤42 days
Trial: 19841476
Drug: Nelotanserin (up
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Nelotanserin (up to 40 mg)
Trial: 17914653
Drug: Ropivacaine 0.54
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ropivacaine 0.54 percent continuous wound infusion
Trial: 17914653
Drug: Normal saline
RxNorm normalized name: Normal Saline Flush
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Normal saline continuous wound infusion
Trial: 12850358
Drug: Pnc PS
RxNorm normalized name: PS
DrugBank: Phosphatidyl serine (DB00144)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Pnc PS vaccine (N=106)
Trial: 8904969
Drug: Alcohol intoxication
RxNorm normalized name: Alcohol
DrugBank: Ethanol (DB00898)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Alcohol intoxication in women (both normally cycling and those taking oral contraceptives)
Trial: 7093092
Drug: Labetalol 100
RxNorm normalized name: HCTZ 25/LABETALOL 100MG TAB
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Labetalol 100 mg orally twice daily
Trial: 7093092
Drug: Labetalol 0.6
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Labetalol 0.6 mg/kg intravenous dose
Trial: 24301248
Drug: Clobetasol propionate
RxNorm normalized name: Clobetasol Propionate
DrugBank: Clobetasol propionate (DB01013)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Clobetasol propionate 0.05% spray (CPS)
Trial: 18677673
Drug: Intensive lifestyle
RxNorm normalized name: Uricalm Intensive
DrugBank: Acetylsalicylic acid (DB00945)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Intensive lifestyle modification and pharmacological treatment
Trial: 15960709
Drug: Oral penicillin
RxNorm normalized name: penicillin G Oral Tablet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral penicillin - 800,000 U penicillin G potassium twice daily for 12 days, repeated every 3 months for 1 year
Trial: 15960709
Drug: Diethylcarbamazine -
RxNorm normalized name: diethylcarbamazine
DrugBank: Diethylcarbamazine (DB00711)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Diethylcarbamazine - 6 mg/kg bodyweight for 12 days, repeated every 3 months for 1 year
Trial: 15960709
Drug: Topical antiseptic
RxNorm normalized name: BENZALKONIUM CHLORIDE 1.3 mg in 1 mL TOPICAL GEL [Germ Free Topical Antiseptic]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Topical antiseptic (betadine ointment)
Trial: 12505919
Drug: Continuous IV
RxNorm normalized name: Ivy Dry Super Continuous Spray
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Continuous IV weight‐adjusted infusion of remifentanil (RIVA)
Trial: 12505919
Drug: Target-controlled infusion
RxNorm normalized name: Diphtheria toxin-il-3 fusion protein targeting IL-3 receptor
DrugBank: Tagraxofusp (DB14731)
FDA approved: yes
EMA approved: yes
PMDA approved: no
Description: Target-controlled infusion for remifentanil (TCIR)
Trial: 30853260
Drug: Fluoroscopically guided
RxNorm normalized name: Autologous CD34+ cells isolated from mobilised peripheral blood by positive selection, modified by CRISPR/Cas9 (clustered regularly interspaced short palindromic repeats/CRISPR-associated protein 9) mediated gene editing consisting of a guide RNA (gRNA)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Fluoroscopically guided injections into the joint capsule (group 1)
Trial: 30853260
Drug: Blind injections
RxNorm normalized name: Io-Blend
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Blind injections to the point of maximum tenderness using sham radiographs (group 2)
Trial: 30853260
Drug: Fluoroscopically guided
RxNorm normalized name: Autologous CD34+ cells isolated from mobilised peripheral blood by positive selection, modified by CRISPR/Cas9 (clustered regularly interspaced short palindromic repeats/CRISPR-associated protein 9) mediated gene editing consisting of a guide RNA (gRNA)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Fluoroscopically guided injections (group 1)
Trial: 30853260
Drug: Blind injections
RxNorm normalized name: Io-Blend
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Blind injections (group 2)